Cool. I wasn't sure if the statistics were sufficiently stock related for Biotech Values.
The stats on "mortality rates" for prostate and breast cancer were interesting. It implies we aren't doing as well at treating these diseases as some people think. Or that we go overboard with worry about slow-growing prostate cancer.
Market Data 
Markets 
AI
